RV521 is a highly effective fusion inhibitor. It designed to treat RSV disease by the target of a surface protein that mediates RSV binding to cellular receptors.

1903763-82-5

C23H22F4N4O

446.44

RV521;RV 521;RV521 free base;RV-521;Sisunatovir

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years